Summary.-Wistar rats were treated with a single dose of 30 mg/kg of DMN or with single doses of 100, 200 or 300 mg/kg of EMS. Tumours of the kidney developed in a few animals receiving EMS and in 33%o of the male and 63% of the female rats treated with DMN alone. In the animals receiving DMN and, 8 hours later, a single dose of 100, 200 or 300 mg/kg of EMS, an additive effect was observed in the induction of kidney tumours. This additive effect was more pronounced in female than in male rats. Morphologically, the tumours were of epithelial and mesenchymal type with a preponderance of the former type. The significance of alkylation of the nucleic acids of the kidney observed with these two compounds is discussed in relation to the present findings.
A SINGLE dose of dimethylnitrosamine (DMN), which is completely metabolized within 5-6 hours, is sufficient to produce a significant incidence of kidney tumours in the rat (Magee and Barnes, 1959) . Ethylmethanesulphonate (EMS) administered in 3 large doses resulted in an increase of lung adenomata and induced epithelial cell tumours of the kidney in mice (Alexander and Connell, 1963) and tumours of the kidney in rats (Swann and Magee, 1969) . Biochemical studies showed that administration of a single dose of DMN or EMS to rats results in the alkylation of some cellular constituents of the kidney, following metabolic activation in the case of DMN and spontaneous breaking down in the case of EMS Magee, 1968, 1971) .
Although the significance of alkylation of cellular macromolecules in initiating a carcinogenic process is not clear, it appears that it is important for the carcinogenic action of DMN and EMS. The induction of kidney tumours after treatment with a single dose of these two alkylating agents is a promising model which allows a study of the correlation between biological response and biochemical interactions with cellular components. The following long-term studies were carried out in order to examine a possible additive effect in the induction of kidney tumours, which might be the result of the total level of alkylation of cellular components after combined treatment with DMN and EMS.
MATERIALS AND METHODS
The materials used were dimethylnitrosamine (DMN), (obtained from Dr F. Kruger), ethylmethanesulphonate (EMS), (T. Schuchardt GmbH Co., Munich, Federal Republic of Germany), and 0 * 9 0 sodium chloride. Groups of Wistar rats of both sexes, 9-10 weeks old, from the colony of the Zentral Institut fur Versuchstiersucht der Deutschen Forschungsgemeinschaft, Hannover, were employed. All animals were observed and weighed once weekly; they were killed 110 weeks after the treatment, by which time all the animals of Group 7 had died spontaneously. Except for a few animals lost through cannibalism, all were autopsied. All the organs, including the central nervous system, were examined macroscopically. Eight graded histological sections were made for each kidney and other pertinent tissues were processed for histological examination.
Groups 1, 2 and 3 received a single i.p. injection of 100, 200 and 300 mg/kg respectively of EMS in 1 0 ml of 0.9% sodium chloride. The solution of EMS was freshly prepared before treatment. Group 4 received a single i.p. injection of 30 mg/kg of DMN in 1 * 0 ml of 0 -9 % sodium chloride. The other groups (Groups 5, 6 and 7) received a single i.p. injection of DMN as in Group 4 and 8 hours later an i.p. injection of 100, 200 or 300 mg/kg of EMS respectively.
A control group received a single i.p. injection of 1 0 ml of 0.9% sodium chloride. The number of rats in each group is given in Table I . in the males and 61, 59 and 710% in the females respectively (Table I) . These data showed an increased incidence of kidney tumours in the males compared with the 33%0 incidence observed in the males of Group 4 receiving DMN alone. The females of Group 5 and 6 showed a similar final incidence of kidney tumours to that of Group 4 (63%)0 whereas the highest tumour yield (71%) was observed in Group 7, receiving the highest dose of EMS in combination with DMN.
Comparison of the percentage of tumour incidences based on the initial number of animals can be misleading if deaths due to causes other than the observed tumours occur at different rates in the various experimental groups. For this reason, the progression with time of the cumulative probability for observing a kidney tumour at death has been calculated by the actuarial method described by Kaplan and Meier (1958) . The actuarial probabilities for observation of kidney tumours at death in animals of Groups 1, 3, 4, 5, 6 and 7 have been plotted on Fig. 1, 2 and 3 . When males and females ( Fig. 1) are examined together, a considerable shortening of the latent period for these tumours was observed in the rats receiving the combined treatments when compared with rats receiving DMN or EMS alone. However, some differences appear when males and females are considered separately. In the females (Fig. 2) , all the rats receiving the combined treatment show a shortening of the latent period with no variation among these 3 groups, whereas in the males (Fig. 3) an earlier appearance of kidney tumours was confined to Group 7. Statistically, 2.-Probability for the observation of a kidney tumour in female rats at death, calculated according to Kaplan and Meier (1958 Among the other types of tumours, no differences were observed between these groups and the DMN-alone treated group, with the possible exception of lung tumours which occur in a slightly higher number.
Another indication of the additive effect of EMS and DMN in their carcinogenic action is given by the multiplicity of tumours induced. As shown in Table II , the ratio of the total number of tumours over the total tumour bearing animals markedly increases in the groups treated with DMN plus EMS.
Morphology
The morphological aspects of the kidney tumours reported here were analogous to those previously described by various authors (Magee and Barnes, 1962; Hard and Butler, 1970; Riopelle and Jasmnin, 1969) . They were of 2 histological types epithelial (Fig. 6) and mesenchymal (Fig. 7) , which developed as multiple growths localized in the cortical region (Fig. 5) . The mesenchymal tumours appeared as large growths with a tendency to necrosis and haemorrhage (Fig. 4) . Occasionally metastases were observed in the lung. A preponderance of adenomata and/or adenocarcinomata over mesenchymal tumours was observed in all the groups. In the EMS-alone treated rats (Groups 1 and 3) bearing a total of 5 kidney tumours, 3 were epithelial and 2 mesenchymal. In the other groups, 90% of the kidney tumours were of the epithelial type. No differences were detected among females and males on the tumour type.
The tumours of the nasal cavities were of various types, such as squamous cell papillomata and carcinomata, adenomata, adenocarcinomata and undifferentiated carcinomata. The lung tumours were 8 adenomata, 4 adenocarcinomata and 3 squamous cell carcinomata.
DISCUSSION
The present studies show an additive effect in the induction of kidney tumours in rats following combined treatment with single doses of EMS and DMN. In addition, the carcinogenicity of EMS has been confirmed.
Previous studies (Swann and Magee, 1969) in female Wistar rats showed that 3 doses of 275 mg/kg of EMS administered over a period of a week were necessary to induce mesenchymal kidney tumours in 50% of the rats, whereas after a single dose of 350 mg/kg, a brain tumour was observed but no kidney tumours. Our results show that a single dose of 100 or 300 mg/kg is sufficient to induce a low incidence of kidney tumours in these rats after a latent period of 90-95 weeks. The fact that no kidney tumours were observed in the studies of Hrushesky, Sampson and Murphy (1972) might be attributed to the early sacrifice of the animals. The rats, treated with DMN alone (Group 4), showed an incidence of 33% of kidney tumours in the males which is comparable with previous data (McLean and Magee, 1970; Schmidt and Murphy, 1966) . The final yield of kidney tumours in females reached an incidence of 63%. A high susceptibility of the females has been previously reported in Wistar and Sprague-Dawley rats (Magee and Barnes, 1962; Riopelle and Jasmin, 1969) .
The additive effect between EMS and DMN in the induction of kidney tumours is more pronounced in the female rats (Fig. 2) , where a higher tumour yield is present in all DMN plus EMS treated groups than in males (Fig. 3) where this effect is confined to the group receiving the highest dose of EMS combined with DMN. The higher multiplicity of tumours as well as the number of lung tumours in rats receiving the combined treatment (Table I and II) suggest that the carcinogenic additive effect is not confined to the kidney but is present to a lesser extent in other organs as well.
The induction of kidney tumours in rats treated with a single dose of various alkylating agents has already been exploited to correlate quantitatively the levels of alkylation in this organ and the tumour yield. Magee (1968, 1971) examined the amount of alkylation in kidney nucleic acids by dimethylnitrosamine, N-nitroso-N-methylurea, methylmethanesulphonate and the corresponding ethyl derivatives and they found a lack of correlation between the amount of alkylation of N-7 in guanine residues by each compound and their carcinogenic activity. In particular, the extent of conversion of guanine to 7-methylguanine was closely similar in the kidneys with dimethylnitrosamine and nitrosomethylurea, both of which induce tumours in this organ. With methylmethanesulphonate, however, the yield of 7-methylguanine in the kidney nucleic acids was of the same order as that found with the 2 nitroso compounds, but no kidney tumours were observed in the rats surviving a single dose of this compound. Similar results were obtained with the corresponding ethylating agents, among which a single dose of 270 mg/kg of EMS produced 5-10 times more 7-ethylguanine in rat kidney DNA than a carcinogenic dose of diethylnitrosamine or ethylnitrosourea. In these studies, a dose as large as 350 mg/kg body weight of EMS failed to induce kidney tumours; in the present studies, however, a single dose of 100 mg/kg body weight was sufficient to induce a low incidence of kidney tumours. However, these experiments Magee, 1968, 1971 ) compared only the extent of alkylation of N-7 of guanine residues, which is the major alkylation site in nucleic acid bases, by these compounds. The question whether other alkylated sites in nucleic acids may be more important in the initiation of the carcinogenic process has been reviewed by Lawley (1972) . As originally suggested by Loveless (1969) and substantiated by Gerchman and Ludlum (1973) , alkylation of the 0-6 atom of guanine can cause mispairing of bases and thus induce transition mutations. O'Connor, Capps and Craig (1973) have shown that O-6-methylguanine is present in hepatic DNA from rats treated with DMN, but none was detected after treatment of the animals with methylmethanesulphonate. EMS is known to react in vitro to the 0-6 position of guanine residues of DNA (Lawley, 1972) .
The additive effect in the induction of kidney tumours in rats by a single dose of DMN and EMS, demonstrated in these studies, suggests that it might be the result of the total nucleic acid alkylation by these two compounds. However, which specific site(s) of alkylated nucleic acid bases is (are) involved in initiating the carcinogenic process remains to be established. Another factor, that could be related to the present findings is the impairment by the EMS of the cellular immune response which is known to occur with various alkylating agents (Kruger, 1972) .
